[Therapeutic behaviour for a HCV+ patient].
Buffet
Catherine
C
Service des maladies du foie et de l'appareil digestif, CHU de Bicêtre, France.
D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001706:Biopsy; D000075202:Contraindications; D019091:Critical Pathways; D004359:Drug Therapy, Combination; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000145:classification / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D006801:Humans; D007279:Injections, Subcutaneous; D007372:Interferons / Q000008:administration & dosage* / Q000009:adverse effects; D008099:Liver / Q000473:pathology; D012254:Ribavirin / Q000008:administration & dosage* / Q000009:adverse effects; D012307:Risk Factors
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons